QNRX — Quoin Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
Brief: Quoin Pharmaceuticals Announces Additional Positive Interim Data From Ongoing Open-Label Netherton Syndrome Clinical Study
Brief: Quoin Pharmaceuticals Announces Positive Interim Data From Two Ongoing Netherton Syndrome Clinical Studies
Brief: Quoin Pharmaceuticals Announces Further International Expansion Of Ongoing Clinical Trials For Netherton Syndrome
Brief: Quoin Pharmaceuticals Announces International Expansion Of Ongoing Clinical Trials For Netherton Syndrome
Brief: Quoin Pharmaceuticals Announces Signing Of Research Agreement With University College Cork, Ireland
Quoin Pharmaceuticals rises on FDA clearance to enroll teenage patients in ongoing studies
Quoin Pharma rises on FDA nod for skin disorder therapy study
U.S. STOCKS ON THE MOVE-Adobe, Accenture, Under Armour, Novavax
Quoin Pharma rises on deal with Russia's Orpharm to sell rare disorder treatment
U.S. STOCKS ON THE MOVE-Forte Biosciences, Sphere 3D, Future Fintech, gold miners
U.S. STOCKS ON THE MOVE-Didi, Forte Biosciences, Future Fintech, MongoDB
NASDAQ RESUMED AT 10:26 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:21 AM
Brief: Cellect Biotechnology Files Registration Statement In Connection With Proposed Strategic Merger Agreement With Quoin Pharmaceuticals
U.S. STOCKS ON THE MOVE-Nike, Boeing, ViacomCBS, GameStop, Cellect Biotechnology, WISeKey International
U.S. STOCKS ON THE MOVE-Evofem Biosciences, Lumentum, Cellect Biotechnology, Nike, Baidu
U.S. STOCKS ON THE MOVE-Cellect Biotechnology, Nike, Lumentum, Evofem Biosciences
U.S. STOCKS ON THE MOVE-Evofem Biosciences, Lumentum, Bionano Genomics